#GenericDrugs #AffordableHealthcare #Biosimilars
www.beckershospitalreview.com
Civica Rx's low-cost insulin, biosimilar launch in US
CivicaScript, a nonprofit generic drug company, has launched insulin glargine-yfgn and ustekinumab-aauz, expanding its national portfolio of low-cost treatments.
